1. FGF 23 and Outcomes in Kidney Disease Arun Chawla, MD Hofstra NS LIJ School of Medicine Nephrology 2. Copyright ©2010 American Society of Nephrology Gutierrez, O. M.…

Slide 1Five year clinical follow-up of the PASSION-trial Five year clinical follow-up of the PASSION-trial Five Year Follow-up after Primary PCI with a Paclitaxel-Eluting…

Slide 1Presenter Disclosure Information Robert E. Michler, M.D. Influence of Left Ventricular Volume Reduction on Outcome After Coronary Artery Bypass Grafting With or Without…

Slide 1I International Symposium on Prevention of Cardiovascular Diseases Kraków 9-11.06.2005 Prevention of Heart Failure after AMI MAŁOPOLSKA STUDY A 2256-Patients Registry…

Slide 1Hodgkin’s Disease an Update. Is more always better? Jeffrey Schriber, M.D. Medical Director Cancer Transplant Institute Virginia G. Piper Cancer Center Slide 2 Slide…

1.Survival analysis Dr HAR ASHISH JINDAL JR2. Contents • • • • • • • • •Survival Need for survival analysis Survival analysis Life table/ Actuarial Kaplan…

1. PRAMI TrialAbdelkader Almanfi, MD, MRCP-UK Texas Heart Institute Journal club 11/04/2013 2. DisclosureI have nothing to disclose except that I am getting free lunches,…

1. Evidence Based Medicine: Wisit Cheungpasitporn, MD.PGY-3, Internal Medicine 2. “Normal Saline is Bad” 3. Normal Saline is not Normal?• May induce or exacerbate:–…

1. SEPSIS ,SEVERE SEPSIS AND SEPTIC SHOCK 2008 UPDATE J.TAVARES,MD,FCCP,FAASM 2. Rivers E et al. N Engl J Med 2001;345:1368-1377 Protocol for Early Goal-Directed Therapy…

Beta Blockers in SIHD : All patients with Should Receive it Beta Blockers in SIHD : Yes, All Patients Should Receive Them ! - Dr. Akshay Mehta 1 Spectrum of SIHD Stable HF…